New York University Cancer Center

New York, New York 10016

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Mesothelioma Clinical Trial
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
Status: Enrolling, Phase II
Updated: 5/22/2008
New York University Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials